Frontiers in Oncology (Sep 2023)
Corrigendum: Case report: deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: three cases reports
Abstract
No abstracts available.Keywords
Frontiers in Oncology (Sep 2023)